Document Detail


Treatment options for polycystic ovary syndrome.
MedLine Citation:
PMID:  21339935     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. The clinical manifestation of PCOS varies from a mild menstrual disorder to severe disturbance of reproductive and metabolic functions. Management of women with PCOS depends on the symptoms. These could be ovulatory dysfunction-related infertility, menstrual disorders, or androgen-related symptoms. Weight loss improves the endocrine profile and increases the likelihood of ovulation and pregnancy. Normalization of menstrual cycles and ovulation could occur with modest weight loss as little as 5% of the initial weight. The treatment of obesity includes modifications in lifestyle (diet and exercise) and medical and surgical treatment. In PCOS, anovulation relates to low follicle-stimulating hormone concentrations and the arrest of antral follicle growth in the final stages of maturation. This can be treated with medications such as clomiphene citrate, tamoxifen, aromatase inhibitors, metformin, glucocorticoids, or gonadotropins or surgically by laparoscopic ovarian drilling. In vitro fertilization will remain the last option to achieve pregnancy when others fail. Chronic anovulation over a long period of time is also associated with an increased risk of endometrial hyperplasia and carcinoma, which should be seriously investigated and treated. There are androgenic symptoms that will vary from patient to patient, such as hirsutism, acne, and/or alopecia. These are troublesome presentations to the patients and require adequate treatment. Alternative medicine has been emerging as one of the commonly practiced medicines for different health problems, including PCOS. This review underlines the contribution to the treatment of different symptoms.
Authors:
Ahmed Badawy; Abubaker Elnashar
Related Documents :
19561095 - Tlr9 activation coupled to il-10 deficiency induces adverse pregnancy outcomes.
3212275 - Effect of pregnancy and fetal development on sheep liver superoxide dismutase activity.
12054385 - The benefits of physical activity during pregnancy.
1183485 - Prostaglandin 15-hydroxydehydrogenase activity during pregnancy in rabbits and rats.
2888995 - Clinic experience of prenatal diagnosis of cystic fibrosis by use of linked dna probes.
10658275 - Prognostic factors in severe twin-twin transfusion syndrome treated by endoscopic laser...
Publication Detail:
Type:  Journal Article     Date:  2011-02-08
Journal Detail:
Title:  International journal of women's health     Volume:  3     ISSN:  1179-1411     ISO Abbreviation:  Int J Womens Health     Publication Date:  2011  
Date Detail:
Created Date:  2011-02-22     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101531698     Medline TA:  Int J Womens Health     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  25-35     Citation Subset:  -    
Affiliation:
Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trends in serum relaxin concentration among elite collegiate female athletes.
Next Document:  Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16?-hydroxyestrone ratio predictive for breast...